Back to KROS
ORBIMED ADVISORS LLC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$8.7M
Q3 2026
Peak value
$16.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $16.4M |
| Q1 2026 | $8.4M |
| Q2 2026 | $8.1M |
| Q3 2026 | $8.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $8.7M | 759.2K | — | — |
| Q2 2026 | $8.1M | 759.2K | — | — |
| Q1 2026 | $8.4M | 759.2K | — | — |
| Q4 2025 | $16.4M | 804.2K | — | — |